• Pipeline
  • Pipeline

Pipeline

  Classification Pipeline Indication Discovery Non-Clinical Phase 1 Phase 2 Phase 3
ASO Immuno-Onco Combination ATB-301 Pancreatic Cancer
  • Discovery
  • Non-Clinical
  • Phase 1
  • Phase 2
  • Phase 3
Phase 1b
Immuno-Onco Combination ATB-320 Pancreatic Cancer (Cholangiocarcinoma,Triple Negative Breast Cancer, Melanoma)
  • Discovery
  • Non-Clinical
  • Phase 1
  • Phase 2
  • Phase 3
Completed Toxicity Study
Targeted-Onco ATB-350 Pancreatic Cancer
  • Discovery
  • Non-Clinical
  • Phase 1
  • Phase 2
  • Phase 3
Discovery
Small
Molecule 		Anti-Fibrosis ATB-610 IPF
  • Discovery
  • Non-Clinical
  • Phase 1
  • Phase 2
  • Phase 3
Discovery
T2DM/HTN FDC ATB-101 Type 2 Diabetes/Hypertension
  • Discovery
  • Non-Clinical
  • Phase 1
  • Phase 2
  • Phase 3
Phase 3

  • Privacy Policy
  • Headquarter.#302, 194-41, Osong-saengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, 28610, Republic of Korea
  • R&D Center.#510 Signature Gwanggyo Knowledge Business Center 37, Poeun-daero 59beon-gil, Suji-gu, Yongin-si, Gyeonggi-do, 16864, Republic of Korea
    • T.043-233-9373
    • F.043-233-9374
    • E.info@autotelic.co.kr

Copyright @AUTOTELIC. All rights reserved.